Skip to navigation Skip to content

Severe facial lipoatrophy Program in Pharmaceutical Benefits Scheme (PBS) 012-18051129

Expand/Collapse all sectionsExpand all



This document outlines details of PBS-subsidised polylactic acid (PLA) for patients with HIV associated severe facial lipoatrophy.

For information on how to process a PBS Authority, see Processing Complex Authority Required Listings.

Severe facial lipoatrophy quick reference

Restrictions

Authority level and section

PA assessment

Processing system

Prescriber type

Prescriber self-serve

Initial

Telephone Electronic

S85: polylactic acid

No

OPA

Must be referred to the accredited injector from an HIV physician.

Yes

Maintenance

Telephone Electronic S85: polylactic acid

No

OPA

Must be referred to the accredited injector from an HIV physician.

Yes